Clinical trial
Study of the Distractibility Syndrome in Patients With Progressive Supranuclear…
NCT00139373 · Groupe Hospitalier Pitie-Salpetriere, Other · Unknown status
Key facts
| NCT number | NCT00139373 |
|---|---|
| Title | Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy |
| Official title | Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy |
| Lead sponsor | Groupe Hospitalier Pitie-Salpetriere, Other |
| Collaborators | Institut National de la Santé Et de la Recherche Médicale, France |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Supranuclear Palsy, Progressive |
| Intervention type | Drug |
| Interventions | donepezil |
| Enrollment | 16 |
| First posted | Aug 31, 2005 |
| Last update posted | Sep 14, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: